2021
DOI: 10.1097/rli.0000000000000788
|View full text |Cite
|
Sign up to set email alerts
|

De Novo Radiomics Approach Using Image Augmentation and Features From T1 Mapping to Predict Gleason Scores in Prostate Cancer

Abstract: Objectives: The aims of this study were to discriminate among prostate cancers (PCa's) with Gleason scores 6, 7, and ≥8 on biparametric magnetic resonance imaging (bpMRI) of the prostate using radiomics and to evaluate the added value of image augmentation and quantitative T1 mapping. Materials and Methods: Eighty-five patients with subsequently histologically proven PCa underwent bpMRI at 3 T (T2-weighted imaging, diffusion-weighted imaging) with 66 patients undergoing additional T1 mapping at 3 T. The PCa le… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 50 publications
0
20
0
Order By: Relevance
“…To remain feasible, many other sequences, including 3D isotropic sequences and quantitative sequences such as T1- and T2-mapping and diffusion-weighted MRI, were not benchmarked, important vendor differences/scanner-specific image processing parameters were neither assessed nor compared, and in vivo experiments were not conducted 47,48 . These are major limitations that should be addressed in future multiscanner, multicenter studies.…”
Section: Discussionmentioning
confidence: 99%
“…To remain feasible, many other sequences, including 3D isotropic sequences and quantitative sequences such as T1- and T2-mapping and diffusion-weighted MRI, were not benchmarked, important vendor differences/scanner-specific image processing parameters were neither assessed nor compared, and in vivo experiments were not conducted 47,48 . These are major limitations that should be addressed in future multiscanner, multicenter studies.…”
Section: Discussionmentioning
confidence: 99%
“…Rather, we focused on stratification of clinically significant PCa by GS risk groups [ 15 , 16 , 17 ]. Table 1 summarizes the 15 studies utilizing MRI-derived radiomic models to predict pathologic GS [ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ], with one study predicting GS upgrading between biopsy and surgery [ 23 ].…”
Section: Resultsmentioning
confidence: 99%
“…In delineating regions of interest, eight studies [ 15 , 17 , 18 , 19 , 22 , 24 , 25 , 27 ] utilized only PI-RADS lesions, while the remaining seven utilized the full prostate [ 16 , 20 , 21 , 23 , 26 , 28 , 29 ]. Feature extraction and selection was most commonly done via minimum redundancy maximum relevance (mRMR) [ 21 , 28 , 29 ] or random forest (RF) [ 15 , 16 , 24 ], and the receiver operator characteristic–area under the curve (ROC-AUC) of the final models ranged from 0.50 to 0.92. Castillo and colleagues [ 27 ] were the only group to perform a multi-institutional external validation of their model for the prediction of GS ≤ 6 versus GS ≥ 7, yielding an ROC-AUC of 0.75.…”
Section: Resultsmentioning
confidence: 99%
“…In prostate cancer, T2 mapping has revealed significantly lower T2 values in cancerous regions 103 , and has shown high diagnostic accuracy in differentiating between chronic prostatitis and cancer 104 . In contrast, T1 mapping has been found to predict Gleason scores 96 . In liver cancer, multiparametric MRI (T1, T2 relaxation times) has been found to be useful in detecting sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy 105 .…”
Section: Mrimentioning
confidence: 89%
“…Their use beyond cardiac imaging has increased, owing to better reconstruction and k-space sampling techniques, e.g., for mapping peritumoral infiltration zones in glioblastoma and anaplastic astrocytoma with T2 mapping 94 , or to identify histological types of lung cancer with T1 mapping 95 . T1 mapping has also been used to predict Gleason scores in prostate cancer 96 , whereas T2 mapping in prostate cancer has been used to differentiate between healthy and cancerous gland tissue 97 .…”
Section: Mrimentioning
confidence: 99%